Maksim Mamonkin

14PUBLICATIONS
68CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsState crimeContract lawMusic not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Apr 27, 2026
Engineering CAR-Vδ2 T cells to boost persistence and anti-tumor function.

|Feb 04, 2026
Enhancing CAR- and TCR-mediated targeting of cancer via an immune synapse-stabilizing receptor.

Chiou-Tsun Tsai, Jorge Ibanez-Vega, Pan Yin

|Sep 04, 2025
CART-007: a license to kill.

Swati Naik, Maksim Mamonkin

|Aug 19, 2025
International consensus guidelines for the conduct and reporting of CAR T-cell clinical trials in AML.

Swati Naik, Richard Aplenc, Susanne H C Baumeister

|Mar 06, 2025
CD7 CAR-T: a bridge to transplant in AML.

Maksim Mamonkin

|Jan 10, 2025
Molecular dynamics at immune synapse lipid rafts influence the cytolytic behavior of CAR T cells.

Ahmed Z Gad, Jessica S Morris, Lea Godret-Miertschin

Pageof 3